Use Of Psilocybin For Mental Health Treatment ‘Not Associated’ With Risk Of Paranoia, American...

Wed, Apr 10

New study published by American Medical Association: Therapeutic doses of psilocybin are "not associated with risk of paranoia and transient thought disorder," and other adverse effects like headaches are "tolerable and resolved within 48 hours." https://t.co/DPncanoCo0

202061

Single-dose psilocybin use is “not associated with risk of paranoia,” while other adverse effects such as headaches are generally “tolerable and resolved within 48 hours”—according to a new scienti...

Discover